Quantum, AI & Health
summary
Claims that GPU-based simulation already models molecular quantum interactions and speeds drug discovery, with GPUs running molecular simulation replacing the old 2030 timeline; demonstration of diamond quantum sensors reading the heart’s magnetic field (MCG) that need AI to extract signals; industry-value estimates of €1–3 trillion for pharma impact and €60–80bn unlocked from drug R&D; current hardware notes of about 150–250 logical qubits needed for basic molecules versus hundreds of physical qubits today, implying a long hardware scale-up.
AI-written summary · about
chapters (9)
- 0:00Introduction to frontier tech
- 1:23Vision and industrial impact
- 5:36Market value in pharmaceuticals
- 6:41Timeline and feasibility
- 10:43Overcoming quantum hurdles
- 12:10Visionary investment focus
- 14:13Workforce and material design
- 16:57Mastery over the matterverse
- 20:23Insider tips and closing
related talks
28mQuantum Cure: How Quantum Computing Will Impact the Future of Healthcare
19mQuantum Computing: Hype, Reality and Business Relevance for Materials Discovery
59mQuantum Computing Concepts
11mEmpowering scientific innovation with HPC AI and Quantum –with Aseem Datar
01h 07mQuantum architecture for utility scale with HPC, AI and Quantum
34mThe True Revolution Lies Ahead of Us
19mQuantum-Centric Data Driven R&D with focus on Life Science
16mBeyond Patterns: The Case for Physics-Grounded AI in Drug Discovery